Lumonus

Lumonus is a Sydney-based company specializing in AI-powered solutions for radiation oncology. Their platform, Lumonus AI, integrates with existing systems to enhance care team coordination, automate administrative tasks, and provide actionable insights, aiming to improve the efficiency and quality of cancer care. The company operates in the United States, Australia, and the United Kingdom, serving over 750 practitioners and supporting more than 180,000 prescriptions. Lumonus has raised A$28 million in Series B funding to scale its oncology workflow solutions globally.

• Healthtech